Contrast enhancement following coiling of intracranial aneurysms in 3T MRI and its relationship to aneurysm recurrence following endovascular treatment
Phase 4
Recruiting
- Conditions
- I67.10
- Registration Number
- DRKS00014644
- Lead Sponsor
- niversitätsklinikum Freiburg
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Clinically indicated follow-up MRI/MRA examination after coiling of a ruptured or unruptured cerebral aneurysm.
Exclusion Criteria
Known Contraindication to Gadolinium contrast agents.
Patients, who for any reason are unable to personally give an informed consent to the study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Contrast enhancement of treated intracranial aneurysms in serial MRI-examinations 6, 18, 36 and 60 months following treatment.
- Secondary Outcome Measures
Name Time Method Recurrence following Coiling in serial MRI/ MR-angiographic examinations 6, 18, 36 and 60 months following treatment.